SearchDictionaryMobileLogin

Ralph D'Agostino Selected Research

Insulin Resistance

09/2007Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults.
10/2004Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
06/2004Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
03/2004Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study.
11/2003Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
10/2003Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
10/2003Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
05/2003Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
08/2002Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study.
04/2002Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
04/2002Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.

Articles by Research Topic

Disease

11Insulin Resistance
09/2007 - 04/2002
8Atherosclerosis (Atheroma)
10/2004 - 04/2002
4Syndrome
06/2007 - 08/2002
2Prostatic Neoplasms (Prostate Cancer)
07/2007 - 06/2006
1Type 2 Diabetes Mellitus (MODY)
04/2008
1Thrombosis (Thrombus)
03/2007
1Memory Disorders (Memory Loss)
12/2006
1Renal Artery Obstruction (Renal Artery Stenosis)
07/2006
1Hypertension (High Blood Pressure)
07/2006
1Cardiomyopathies (Cardiomyopathy)
06/2006
1Heart Failure
11/2004
1Contact Dermatitis (Eczema, Contact)
09/2004
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2004
1Prediabetic State (Prediabetes)
10/2003
1Inflammation
10/2003
1Onychomycosis (Tinea Unguium)
07/2003
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2003

Drug/Important Bio-Agent (IBA)

5Insulin (Novolin)FDA Link
03/2004 - 04/2002
2HDL CholesterolIBA
04/2008 - 10/2004
2ApolipoproteinsIBA
10/2004 - 11/2003
2Plasminogen Activators (Plasminogen Activator)IBA
05/2003 - 04/2002
1pioglitazone (Actos)FDA Link
04/2008
1Biological Markers (Surrogate Marker)IBA
09/2007
1Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA
07/2007
1lucinactantIBA
06/2007
1N-Methylaspartate (NMDA)IBA
12/2006
1GadoliniumIBA
06/2006
1lycopeneIBA
06/2006
1Hydralazine (Apresoline)FDA LinkGeneric
11/2004
1Isosorbide Dinitrate (Isordil)FDA LinkGeneric
11/2004
1AllergensIBA
09/2004
1Glucose (Dextrose)FDA LinkGeneric
06/2004
1LDL CholesterolIBA
11/2003
1Itraconazole (Sporanox)FDA LinkGeneric
07/2003
1terbinafine (Lamisil)FDA LinkGeneric
07/2003
1Acute-Phase Proteins (Acute-Phase Protein)IBA
04/2002
1ProinsulinIBA
04/2002

Therapy/Procedure

2Stents
03/2007 - 07/2006
1Drug-Eluting Stents
03/2007
1Home Nursing (Nursing, Home)
01/2003